Yeah.

Technology.

What is it all about?

And we said maybe we can skip this whole expensive and long process of really measuring the RNA and use AI, deep learning, to look at this image.

Really a simple image that a pathologist looks at that costs zero dollars and understand which genes are upregulated, which genes are

downregulated, and from that directly from this image predict the response to treatment.

And this is where we see the next step in AI, without AI or even two years ago, I think

this would have been impossible to do.

Hello and welcome to Danny in the Valley.

I am your host, Danny Ford's in the West Coast correspondent for the Sunday Times.

And this week, we're going to cover the gamut, the AI gamut from computers that debate humans and sometimes win, sometimes lose.

And cancer hunting AI and everything in between.

On today's show, we have a woman who is in the center of it all. Her name is Ranit Ahoranov. She is a computational neuroscientist and chief

technology officer of a company called Pangia Biomed. They're a startup using AI to target cancer

treatments, especially for people who have very difficult,

very aggressive cancers for which there are not a lot of obvious cures. And I want to have

her on because there, you know, there's a lot of hand waving about how AI is going to change

everything. Medicine at your fingertips. An AI doctor in your pocket. That's better than any

doctor on planet Earth etc it's rolled

out as kind of one of these big prizes almost the big prize of AI and pangio which is based in

israel is right in the engine room here using AI for a very specific purpose and it appears potentially

you're having hugely dramatic results when it comes to figuring out which

...